{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:21:18Z","timestamp":1787988078945,"version":"build-2784847793"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019573","name":"Amsterdam University Medical Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["015.015.042"],"award-info":[{"award-number":["015.015.042"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91719372"],"award-info":[{"award-number":["91719372"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.virusres.2024.199308","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:06:40Z","timestamp":1704996400000},"page":"199308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns"],"prefix":"10.1016","volume":"341","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-5075","authenticated-orcid":false,"given":"Ana","family":"Chumbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Grobben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Capella-Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie M.","family":"Koekkoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Zon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Slamanig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina J.","family":"Merat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwinten","family":"Sliepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janke","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-8161","authenticated-orcid":false,"given":"Marit J.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2024.199308_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113087","article-title":"Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection","volume":"495","author":"Adhikari","year":"2021","journal-title":"J. Immunol. Method."},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.virusres.2024.199308_bib0003","first-page":"1","article-title":"Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies","volume":"70","author":"Bankwitz","year":"2020","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"036331000","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med"},{"issue":"23","key":"10.1016\/j.virusres.2024.199308_bib0005","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199308_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J. Immunol. Method."},{"key":"10.1016\/j.virusres.2024.199308_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01851","article-title":"A sample-sparing multiplexed ADCP assay","volume":"10","author":"Butler","year":"2019","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.virusres.2024.199308_bib0009","first-page":"4036","article-title":"Signatures of V H 1-69-derived hepatitis C virus neutralizing antibody precursors dened by binding to envelope glycoproteins","volume":"4036","author":"Capella-Pujol","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.27298","article-title":"Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a","volume":"65","author":"Carlsen","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45461-z","article-title":"Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery","volume":"9","author":"Christiansen","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.virusres.2024.199308_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jgv.0.001801","article-title":"Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus","volume":"103","author":"Chumbe","year":"2022","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0014","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology amy","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"issue":"7213","key":"10.1016\/j.virusres.2024.199308_bib0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature07352","article-title":"Challenges in the development of an HIV-1 vaccine","volume":"455","author":"Barouch","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0016","first-page":"1","article-title":"Development and validation of 13-plex luminex-based assay for measuring human serum antibodies to streptococcus pneumoniae capsular polysaccharides","volume":"3","author":"Danka","year":"2018","journal-title":"Clin. Sci. Epidemiol."},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4571-5","article-title":"A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice","volume":"19","author":"Dawood","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0018","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2468-1253(21)00073-X","article-title":"The hunt for a vaccine for hepatitis C virus continues","volume":"6","year":"2021","journal-title":"Lance. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0019","first-page":"783","article-title":"Confidence limits on phylogenies\u202f: an approach using the bootstrap","volume":"39","author":"Felsenstein","year":"1985","journal-title":"Society for the Study of Evolution"},{"issue":"32","key":"10.1016\/j.virusres.2024.199308_bib0020","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/QAD.0000000000002011","article-title":"Antibody-dependent cellular cytotoxicity (ADCC) in HIV infection","volume":"13","author":"Forthal","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2024.199308_bib0021","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymeth.2019.01.012","article-title":"The development of a multiplex serological assay for avian influenza based on Luminex technology","volume":"158","author":"Germeraad","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.virusres.2024.199308_bib0022","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"6205","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012"},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ve\/veac007","article-title":"Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance","volume":"8","author":"G\u00f6mer","year":"2022","journal-title":"Virus Evol."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0047","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00405-22","article-title":"Decreased passive Immunity to respiratory viruses through human milk during the COVID-19 pandemic","volume":"10","author":"Grobben","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virusres.2024.199308_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.70330","article-title":"Cross-reactive antibodies after sars-cov-2 infection and vaccination","volume":"10","author":"Grobben","year":"2021","journal-title":"Elife"},{"issue":"24","key":"10.1016\/j.virusres.2024.199308_bib0025","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1128\/JVI.01569-08","article-title":"Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies","volume":"82","author":"Grove","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199308_bib0026","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"1","article-title":"Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer","volume":"118","author":"Guest","year":"2021"},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody- mediated protection against Ebola virus","volume":"24","author":"Gunn","year":"2019","journal-title":"Cell Host Microb."},{"issue":"22","key":"10.1016\/j.virusres.2024.199308_bib0028","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2024.199308_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13081596","article-title":"Hepatitis c virus vaccine research: time to put up or shut up","volume":"13","author":"Hartlage","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2024.199308_bib0030","unstructured":"Heatmap hierarchical Clustering. (n.d.). Retrieved from http:\/\/www.hiv.lanl.gov\/content\/sequence\/HEATMAP\/heatmap.html."},{"issue":"6","key":"10.1016\/j.virusres.2024.199308_bib0031","doi-asserted-by":"crossref","first-page":"e02262","DOI":"10.1128\/JVI.02262-16","article-title":"Characterization of hepatitis C virus (HCV) envelope diversification from acute to chronic infection within a sexually transmitted HCV cluster by using single-molecule, real-time sequencing","volume":"91","author":"Ho","year":"2017","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0032","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores","volume":"157","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0033","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.virusres.2024.199308_bib0034","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1128\/JVI.78.17.9224-9232.2004","article-title":"Hepatitis C virus E2 Has three immunogenic domains containing conformational epitopes with distinct properties and biological functions","volume":"78","author":"Keck","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein","volume":"87","author":"Keck","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/Spectrum.00731-21","article-title":"Saliva SARS-CoV-2 antibody prevalence in children","volume":"9","author":"Keuning","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0037","first-page":"717","article-title":"Broadly neutralizing antibody mediated clearance of human hepatitis C virus","volume":"24","author":"Kinchen","year":"2018","journal-title":"Infection"},{"issue":"17","key":"10.1016\/j.virusres.2024.199308_bib0038","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"Lambers","year":"2011","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0039","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2024.199308_bib0040","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"E82","article-title":"Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms","volume":"115","author":"Mankowski","year":"2018"},{"issue":"MAY","key":"10.1016\/j.virusres.2024.199308_bib0041","first-page":"1","article-title":"A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice","volume":"10","author":"Masavuli","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.virusres.2024.199308_bib0042","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.00039-15","article-title":"Adaptive mutations enhance assembly and cell-to-cell transmission of a high-titer hepatitis C virus genotype 5a core-NS2 JFH1-based recombinant","volume":"89","author":"Mathiesen","year":"2015","journal-title":"J. Virol."},{"issue":"6161","key":"10.1016\/j.virusres.2024.199308_bib0043","first-page":"931","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0044","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/hep.24076","article-title":"Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak","volume":"53","author":"Merani","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.02.013","article-title":"Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance","volume":"71","author":"Merat","year":"2019","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.virusres.2024.199308_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0165047","article-title":"Hepatitis C virus broadly neutralizing monoclonal antibodies isolated 25 years after spontaneous clearance","volume":"11","author":"Merat","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0048","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/COH.0000000000000442","article-title":"Neutralization tiers of HIV-1","volume":"13","author":"Montefiori","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0049","first-page":"108","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"6","key":"10.1016\/j.virusres.2024.199308_bib0050","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virusres.2024.199308_bib0051","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJMoa2023345","article-title":"Randomized trial of a vaccine regimen to prevent chronic HCV infection","volume":"384","author":"Page","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2024.199308_bib0052","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"6025","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007"},{"issue":"8","key":"10.1016\/j.virusres.2024.199308_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110859","article-title":"Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening","volume":"39","author":"Pfaff-Kilgore","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.virusres.2024.199308_bib0054","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.virusres.2024.199308_bib0055","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"E6946","article-title":"Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: implications for vaccine design","volume":"113 (45)","author":"Pierce","year":"2016"},{"issue":"7","key":"10.1016\/j.virusres.2024.199308_bib0056","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vacc. Immunol."},{"issue":"23","key":"10.1016\/j.virusres.2024.199308_bib0057","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1128\/JVI.02052-12","article-title":"Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody","volume":"86","author":"Potter","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0058","first-page":"406","article-title":"The neighbor-joining method: a new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol. Biol. Evol."},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0059","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2021.10.005","article-title":"An antigenically diverse, representative panel of envelope glycoproteins for hepatitis C virus vaccine development","volume":"162","author":"Salas","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.virusres.2024.199308_bib0060","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered categorization of a diverse panel of HIV-1 env pseudoviruses for assessment of neutralizing antibodies","volume":"84","author":"Seaman","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199308_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2022.853410","article-title":"Atypical antibody dynamics during human coronavirus HKU1 infections","volume":"13","author":"Sechan","year":"2022","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0062","doi-asserted-by":"crossref","first-page":"22","DOI":"10.32607\/20758251-2019-11-4-22-32","article-title":"Non-neutralizing antibodies directed at conservative influenza antigens","volume":"11","author":"Sedova","year":"2019","journal-title":"Acta Naturae"},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0063","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virusres.2024.199308_bib0064","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0065","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1038\/s41467-022-34961-8","article-title":"Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate","volume":"13","author":"Sliepen","year":"2022","journal-title":"Nat. Commun."},{"issue":"261","key":"10.1016\/j.virusres.2024.199308_bib0066","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.virusres.2024.199308_bib0067","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol. Biol. Evol."},{"issue":"17","key":"10.1016\/j.virusres.2024.199308_bib0068","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/QAD.0000000000000838","article-title":"Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men","volume":"29","author":"Thomas","year":"2015","journal-title":"Aids"},{"issue":"6617","key":"10.1016\/j.virusres.2024.199308_bib0069","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.abn9884","article-title":"Structure of the Hepatitis C Virus E1E2 Glycoprotein Complex","volume":"378","author":"Torrents de la Pe\u00f1a","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.virusres.2024.199308_bib0070","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/v13061027","article-title":"Structural and biophysical characterization of the HCV E1E2 heterodimer for vaccine development","volume":"13","author":"Toth","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.virusres.2024.199308_bib0071","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1209\/epl\/i1998-00224-x","article-title":"Statistics of Voronoi cells of slightly perturbed face-centered cubic and hexagonal close-packed lattices","volume":"42","author":"Troadec","year":"1998","journal-title":"Europhys. Lett."},{"issue":"7","key":"10.1016\/j.virusres.2024.199308_bib0072","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/JVI.02700-15","article-title":"A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance","volume":"90","author":"Urbanowicz","year":"2015","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2024.199308_bib0073","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1099\/jgv.0.000537","article-title":"Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay","volume":"97","author":"Urbanowicz","year":"2016","journal-title":"J. Gener. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003991","article-title":"Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: a prospective cohort study","volume":"19","author":"van Gils","year":"2022","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.virusres.2024.199308_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-018-2465-4","article-title":"Optimization of a magnetic bead-based assay (MAGPIX\u00ae-Luminex) for immune surveillance of exposure to malaria using multiple Plasmodium antigens and sera from different endemic settings","volume":"17","author":"Varela","year":"2018","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.virusres.2024.199308_bib0076","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.28989","article-title":"The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs","volume":"65","author":"Vietheer","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2024.199308_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01457","article-title":"Influenza and antibody-dependent cellular cytotoxicity","volume":"10","author":"Von Holle","year":"2019","journal-title":"Front. Immunol."},{"issue":"27","key":"10.1016\/j.virusres.2024.199308_bib0078","article-title":"Antigenic Waves of Virus \u2013 Immune Coevolution","volume":"118","author":"Walczak","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.virusres.2024.199308_bib0079","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1099\/jgv.0.000608","article-title":"Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles","volume":"97","author":"Wasilewski","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2024.199308_bib0081","unstructured":"World Health Organization. (n.d.). WHO | Hepatitis C. Retrieved May 16, 2023, from http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/."},{"key":"10.1016\/j.virusres.2024.199308_bib0082","series-title":"WHO Elimination-of-Hepatitis-by-2030","year":"2023"},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jcm.02348-21","article-title":"Development of a bead-based multiplex assay for use in multianalyte screening and surveillance of HIV, viral hepatitis, syphilis, and herpes","volume":"60","author":"Yufenyuy","year":"2022","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2024.199308_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001609","article-title":"Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates","volume":"20","author":"Zhu","year":"2022","journal-title":"PLoS Biol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:21:56Z","timestamp":1759155716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170224000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":81,"alternative-id":["S0168170224000017"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199308","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199308"}}